Waverley Pharma Inc. (TSXV: WAVE)
Health Care · Biotechnology · CA
CA$0.01
-33.33% today · -50.0% 1Y
Waverley Pharma Inc. (TSXV: WAVE) operates in the Biotechnology industry within the Health Care sector. The company is valued at $378.46K.
Over the last twelve months the share price has lost 50.0%, trading between 0.01 and 0.04.
Tweenvest scores Waverley Pharma Inc. across four factors: quality 23/100, value 63/100, growth 72/100. Its strongest factor is growth.
WAVE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $378.46K
- Revenue (TTM)
- $826.89K
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- 1.46
- 52-week high
- CA$0.04
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 54.00M
- Employees
- —
- Next earnings
- —
About Waverley Pharma Inc.
Waverley Pharma, Inc. is a pharmaceutical company, which engages in the commercialization and development of oncology drugs. Its products include Pemetrexed, WAV-102, and PARP-1 Inhibitors. The company was founded in 2014 and is headquartered in Winnipeg, Canada.
- ISIN
- CA94357L1058
- Founded
- 2014
- Listed since
- Oct 27, 2017
- Exchange
- TSX Venture Exchange
- Currency
- CAD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vaxil Bio Ltd.TSXV: VXL | $406.64K | CA$0.15 | -3.33% |
| Aditxt, Inc.OTCPK: ADTX | $399.19K | $0.00 | -33.33% |
| ZyVersa Therapeutics, Inc.OTCPK: ZVSA | $388.60K | $0.05 | -39.91% |
| Actavia Life Sciences, Inc.OTCPK: RASP | $385.91K | $— | — |
| Paion AGDB: PA8K | $373.18K | €0.05 | +1.09% |
| bioXXmed AGDB: T5O | $304.58K | €1.00 | -4.76% |
| ChitogenX Inc.CNSX: CHGX | $303.81K | CA$— | — |
| co.don AGDB: CNW | $285.60K | €0.01 | +18.75% |
Figures last refreshed Oct 18, 2026.